Identification of neuroprotective properties of anti-MAG antibody: A novel approach for the treatment of stroke?

Journal of Cerebral Blood Flow and Metabolism

Volumn 25, Issue 1, 2005, Pages 98-107

  Irving, Elaine A ^a   Vinson, Mary ^a   Rosin, Claudia ^a   Roberts, Jenny C ^a   Chapman, Debra M ^a   Facci, Laura ^a   Virley, David J ^a   Skaper, Stephen D ^a   Burbidge, Stephen A ^a   Walsh, Frank S ^a   Hunter, A Jacqueline ^a   Parsons, Andrew A ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

CNS recovery; Middle cerebral artery occlusion; Monoclonal antibody; Myelin associated glycoprotein; Neuroprotection; Oligodendrocyte

Indexed keywords

GLUTAMIC ACID; IMMUNOGLOBULIN G1 ANTIBODY; MONOCLONAL ANTIBODY; MYELIN ASSOCIATED GLYCOPROTEIN; MYELIN ASSOCIATED GLYCOPROTEIN ANTIBODY; NEUROPROTECTIVE AGENT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; BRAIN VENTRICLE; CHO CELL; CONTROLLED STUDY; HUMAN; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOTOR PERFORMANCE; NERVE CELL; NERVE CELL NECROSIS; NEUROPROTECTION; NEWBORN; NONHUMAN; OLIGODENDROGLIA; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; STROKE; WESTERN BLOTTING;

ANIMALS; ANTIBODIES, MONOCLONAL; BRAIN; CELL DEATH; CEREBROVASCULAR ACCIDENT; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUTAMIC ACID; IMMUNOGLOBULIN G; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; MICE; MYELIN SHEATH; MYELIN-ASSOCIATED GLYCOPROTEIN; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; REGENERATION;

EID: 19944427345     PISSN: 0271678X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jcbfm.9600011     Document Type: Article

References (53)

1. Back SA, Gan X, Li Y, Rosenberg PA, Volpe JJ (1998) Maturation-dependent vulnerability of oligodendrocytes to oxidative stress-induced death caused by glutathione depletion. J Neurosci 18:6241-53
2. Bard F, Cannon C, Barbour R, Burke RL, Games D, Grajeda H, Guido T, Hu K, Huang J, Johnson-Wood K, Khan K, Kholodenko D, Lee M, Lieberburg I, Motter R, Nguyen M, Soriano F, Vasquez N, Weiss K, Welch B, Seubert P, Schenk D, Yednock T (2000) Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nat Med 6:916-9
3. Brosamle C, Huber AB, Fiedler M, Skerra A, Schwab ME (2000) Regeneration of lesioned corticospinal tract fibers in the adult rat induced by recombinant, humanized IN-1 antibody fragment. J Neurosci 20:8061-8
4. Corbett D, Nurse S (1998) The problem of assessing effective neuroprotection in experimental cerebral ischemia. Prog Neurobiol 54:531-48
5. Deng W, Rosenberg PA, Volpe JJ, Jensen FE (2003) Calcium-permeable AMPA/kainate receptors mediate toxicity and preconditioning by oxygen-glucose deprivation in oligodendrocyte precursors. Proc Natl Acad Sci USA 100:6801-6
6. Du Y, Dreyfus C (2002) Oligodendrocytes as providers of growth factors. J Neurosci Res 68:647-54
7. Fields RD, Stevens-Graham B (2002) New insights into neuron-glia communication. Science 298:556-62
8. Ferguson B, Matyszak MK, Esiri MM, Perry VH (1997) Axonal damage in acute multiple sclerosis lesions. Brain 120:393-9
9. Hunter AJ, Hatcher J, Virley D, Nelson P, Irving EA, Hadingham SJ, Parsons AA (2000) Functional assessment in mice and rats after focal stroke. Neuropharmacology 39:806-16
10. Hunter AJ, Mackay KB, Rogers DC (1998) To what extent have functional studies of ischemia in animals been useful in the assessment of potential neuroprotective drugs? TIPS 19:59-66
11. Irving EA, Bentley DL, Parsons AA (2001) Assessment of white matter injury following prolonged focal cerebral ischemia in the rat. Acta Neuropathol (Berl) 102:627-35
12. Irving EA, Yatsushiro K, McCulloch J, Dewar D (1997) Rapid alteration of tau in oligodendrocytes after focal ischemic injury in the rat: involvement of free radicals. J Cereb Blood Flow Metab 17:612-22
13. Jaramillo ML, Afar DE, Almazan G, Bell JC (1994) Identification of tyrosine 620 as the major phosphorylation site of myelin-associated glycoprotein and its implication in interacting with signaling molecules. J Biol Chem 269:27240-5
14. Jones MW, Errington ML, French PJ, Fine PJ, Bliss TVP, Garel S, Charney P, Bozon B, Laroche S, Davis S (2001) A requirement for the immediate early gene Zif268 in the expression of late LTP and long-term memories. Nat Neurosci 4:289-96
15. Kursula P, Lehto VP, Heape AM (2000) S100beta inhibits the phosphorylation of the L-MAG cytoplasmic domain by PKA. Brain Res Mol Brain Res 76:407-10
16. Kursula P, Lehto VP, Heape AM (2001) The small myelin-associated glycoprotein binds to tubulin and microtubules. Brain Res Mol Brain Res 87:22-30
17. Lappe-Siefke C, Goebbels S, Gravel M, Nicksch E, Lee J, Braun PE, Griffiths IR, Nave K-A (2003) Disruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination. Nat Genet 33:366-74
18. Lassman H, Bartsch U, Montag D, Schachner M (1997) Dying-back oligodendropathy: a late sequel of myelin-associated glycoprotein deficiency. Glia 19:104-10
19. Longa ZEL, Weinstein PR, Carlson S, Cummins R (1989) Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20:84-91
20. Lovas G, Szilagyi N, Majtenyi K, Palkovits M, Komoly S (2000) Axonal changes in chronic demyelinated cervical spinal cord plaques. Brain 123:308-17
21. Ma J, Endres M, Moskowitz MA (1998) Synergistic effects of caspase inhibitors and MK-801 in brain injury after transient focal cerebral ischemia in mice. Br J Pharmacol 124:756-62
22. Mackay KB, Bailey SJ, King PD, Patel S, Hamilton TC, Campbell CA (1996) Neuroprotective effect of recombinant neutrophil inhibitory factor in transient focal cerebral ischemia in the rat. Neurodegeneration 5:319-23
23. Mears S, Schachner M, Brushart TM (2003) Antibodies to myelin-associated glycoprotein accelerate preferential motor reinnervation. J Periph Nervous System 8:91-9
24. Minematsu K, Fisher M, Li L, Sotak CH (1993) Diffusion and perfusion magnetic resonance imaging studies to evaluate a noncompetitive N-methyl-D-aspartate antagonist and reperfusion in experimental stroke in rats. Stroke 24:2074-81
25. Niederost B, Oertle T, Fritsche J, McKinney A, Bandtlow CE (2002) Nogo-A and myelin-associated glycoprotein mediate neurite growth inhibition by antagonistic regulation of RhoA and Rac1. J Neurosci 22:10368-76
26. Oka A, Belliveau MJ, Rosenburg PA, Volpe JJ (1993) Vulnerability of oligodendroglia to glutamate: pharmacology, mechanisms and prevention. J Neurosci 13:1441-53
27. Papadopoulos CM, Tsai SY, Alsbiei T, O'Brien TE, Schwab ME, Kartje GL (2002) Functional recovery and neuroanatomical plasticity following middle cerebral artery occlusion and IN-1 antibody treatment in the adult rat. Ann Neurol 51:433-41
28. Poltorak M, Sadoul R, Keilhauer G, Landa C, Fahrig T, Schachner M (1987) Myelin-associated glycoprotein, a member of the L2/HNK-1 family of neural cell adhesion molecules, is involved in neuron-oligodendrocyte and oligodendrocyte-oligodendrocyte interaction. J Cell Biology 105:1893-9
29. Poduslo JF, Curran GL (2001) Amyloid β peptide as a vaccine for Alzheimer's disease involves receptor-mediated transport at the blood-brain barrier. Neuro-Report 12:3197-200
30. Sánchez-Gómez MV, Matute C (1999) AMPA and kainate receptors each mediate excitotoxicity in oligodendroglial cultures. Neurobiol Dis 6:475-85
31. Schnell L, Schwab ME (1993) Sprouting and regeneration of lesioned corticospinal tract fibres in the adult rat spinal cord. Eur J Neurosci 5:1156-71
32. Schubert D, Piasecki D (2001) Oxidative glutamate toxicity can be a component of the excitotoxicity cascade. J Neurosci 21:7455-62
33. Simpson JB, Mangiapane ML, Dellmann HD (1978) Central receptor sites for angiotensin-induced drinking: a critical review. Fed Proc 37:2676-82
34. Skaper SD, Facci L, Milani D, Leon A, Toffano G (1990) Culture and use of primary and clonal neural cells. In: Methods in neurosciences, Vol. 2 (Conn PM, ed), San Diego: Academic Press, 17-33
35. Stroemer RP, Kent TA, Hulsebosch CE (1995) Neocortical neural sprouting, synaptogenesis and behavioural recovery following neocortical infarction in rats. Stroke 26:2135-44
36. Stroemer RP, Kent TA, Hulsebosch CE (1998) Enhanced neocortical neural sprouting, synaptogenesis, and behavioral recovery with D-amphetamine therapy after neocortical infarction in rats. Stroke 29:2381-95
37. Torigoe K, Lundborg G (1998) Selective inhibition of early axonal regeneration by myelin-associated glycoprotein. Expt Neurol 150:254-62
38. Thallmair M, Metz GAS, Z'Graggen WJ, Raineteau O, Kartje GL, Scwab ME (1998) Neurite growth inhibitors restrict structural plasticity and functional recovery following corticospinal tract lesions. Nat Neurosci 1:124-31
39. Umemori H, Sato S, Yagi T, Aizawa S, Yamamoto T (1994) Initial events of myelination involve Fyn tyrosine kinase signalling. Nature 367:572-6
40. Valeriani V, Dewar D, McCulloch J (2000) Quantitative assessment of ischemic pathology in axons, oligodendrocytes, and neurons: attenuation of damage after transient ischemia. J Cereb Blood Flow Metab 20:765-71
41. Vargo JM, Marshall JF (1996) Frontal cortex ablation reversibly decreases striatal zif/268 and junB expression: temporal correspondence with sensory neglect and its spontaneous recovery. Synapse 22:291-303
42. Vinson M, Rausch O, Maycox PR, Prinjha RK, Chapman D, Morrow R, Harper AJ, Dingwall C, Walsh FS, Burbidge SA, Riddell DR (2003) Lipid rafts mediate the interaction between myelin-associated glycoprotein (MAG) on myelin and MAG-receptors on neurons. Mol Cell Neurosci 22:344-52
43. Vinson M, Strijbos PJLM, Rowles A, Facci L, Moore SE, Simmons DL, Walsh FS (2001) Myelin-associated glycoprotein interacts with ganglioside GT1b: a mechanism for neurite outgrowth inhibition. J Biol Chem 276:20280-5
44. Virley D, Beech JS, Smart SC, Williams SC, Hodges H, Hunter AJ (2000) A temporal MRI assessment of neuropathology after transient middle cerebral artery occlusion in the rat: correlations with behaviour. J Cereb Blood Flow Metab 20:563-82
45. Vyas AA, Patel HV, Fromholt SE, Heffer-Lauc M, Vyas KA, Dang J, Schachner M, Schnaar RL (2002) Gangliosides are functional nerve cell ligands for myelin-associated glycoprotein (MAG), an inhibitor of nerve regeneration. Proc Natl Acad Sci USA 99:8412-7
46. Wallace CS, Withers GS, Weiler IJ, George JM, Clayton DF, Greenough WT (1995) Correspondence between sites of NGFI-A induction and sites of morphological plasticity following exposure to environmental complexity. Brain Res Mol Brain Res 32:211-20
47. Wang JQ, Daunais JB, McGinty JF (1994) NMDA receptors mediate amphetamine-induced upregulation of zif/268 and preprodynorphin mRNA expression in rat striatum. Synapse 18:343-53
48. Wang KC, Kim JA, Sivasankaran R, Segal R, He Z (2002) p75 interacts with the Nogo receptor as a co-receptor for Nogo, MAG and OMgp. Nature 420:74-8
49. Wiessner C, Bareyre FM, Allegrini PR, Mir AK, Frentzel S, Zurini M, Schnell L, Oertle T, Schwab ME (2003) Anti-Nogo antibody infusion 24 h after experimental stroke. Improved behavioural outcome and corticospinal plasticity in normotensive and spontaneously hypertensive rats. J Cereb Blood Flow Metab 23:154-65
50. Wilkins A, Majed H, Layfield R, Compston A, Chandran S (2003) Oligodendrocytes promote neuronal survival and axonal length by distinct intracellular mechanisms: a novel role for oligodendrocyte-derived glial cell line-derived neurotrophic factor. J Neurosci 23:4967-74
51. Wong EV, David S, Jacob MH, Jay DG (2003) Inactivation of myelin-associated glycoprotein enhances optic nerve regeneration. J Neuroscience 23:3112-7
52. Woolf CS, Bloechlinger S (2002) It takes more than two to Nogo. Science 297:1132-4
53. Yang L, Zeller C, Shaper NL, Kiso M, Hasegawa A, Shapiro RE, Schnaar RL (1996) Gangliosides are neuronal ligands for myelin-associated glycoprotein. Proc Natl Acad Sci USA 93:814-8